Study guide

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology

Key Takeaways Explain This Topic AI

Levodopa has a 1-3 hour half-life; continue it through the morning of surgery and resume immediately, because abrupt withdrawal causes severe rigidity and a neuroleptic malignant-like syndrome.

Central dopamine antagonists (metoclopramide, droperidol, haloperidol, promethazine, prochlorperazine) are contraindicated in Parkinson disease; ondansetron and dexamethasone are safe antiemetics.

In multiple sclerosis a core temperature rise of only 1 degree Celsius can trigger a relapse; succinylcholine is avoided with significant paresis and spinal anesthesia is relatively contraindicated.

Succinylcholine is contraindicated in ALS and Guillain-Barre syndrome because of extrajunctional acetylcholine receptor upregulation and hyperkalemia.

Home cholinesterase inhibitors for Alzheimer disease (donepezil, rivastigmine) prolong succinylcholine and antagonize nondepolarizing blockade.

Last updated: August 2026

Why This Topic Matters on the NCE

Domain I of the NCE content outline lists neurodegenerative diseases , myelin diseases , and neuropathies as separate pathophysiology sub-topics, and Domain I.C.12.c lists antiparkinsonian drugs as their own pharmacologic class. These patients arrive for routine surgery constantly, and almost every question about them hinges on one of three decisions: which neuromuscular blocking agent is safe , which antiemetic is safe , and what happens if the home drug is withheld .

1. Parkinson Disease: Dopamine Depletion and the Drugs That Make It Worse

Parkinson disease (PD) is degeneration of dopaminergic neurons in the substantia nigra pars compacta , depleting dopamine in the striatum. Symptoms appear once roughly 80% of dopaminergic neurons are lost. The loss of dopaminergic inhibition leaves unopposed cholinergic activity in the basal ganglia, producing the classic tetrad: resting ("pill-rolling") tremor, cogwheel rigidity, bradykinesia, and postural instability.

Perioperative implications beyond the movement disorder

System Finding Anesthetic consequence

Airway/pulmonary Pharyngeal and laryngeal muscle dysfunction, sialorrhea, weak cough Silent aspiration; consider full-stomach precautions

Respiratory Chest-wall rigidity, restrictive ventilatory defect, upper-airway obstruction on flow-volume loop Postoperative respiratory failure risk

Autonomic Orthostatic hypotension, blunted baroreflex, dysrhythmias Exaggerated hypotension on induction and positioning

  • CNS Depression, dementia (~30%), hallucinations Higher postoperative delirium risk
  • GI Delayed gastric emptying, constipation Erratic absorption of oral levodopa
  • Levodopa pharmacology and the withdrawal trap

Levodopa is the dopamine precursor that crosses the blood-brain barrier; carbidopa is a peripheral decarboxylase inhibitor that prevents systemic conversion (reducing nausea and allowing lower levodopa doses). The critical NCE fact is that levodopa has an elimination half-life of only 1 to 3 hours .

Continue levodopa/carbidopa up to and including the morning of surgery , and restart it as early as possible postoperatively — through an orogastric or nasogastric tube if the case is long.

Abrupt withdrawal produces severe rigidity, worsened ventilation, and can precipitate a neuroleptic malignant-like syndrome (hyperthermia, rigidity, rhabdomyolysis, altered mental status) that is clinically confusable with malignant hyperthermia but is not triggered by volatiles and is not treated primarily with dantrolene.

Drugs that are contraindicated or hazardous

Central dopamine (D2) antagonists worsen parkinsonism and must be avoided : metoclopramide, droperidol, haloperidol, promethazine, prochlorperazine.

Safe antiemetic choices : ondansetron (5-HT3 antagonist), dexamethasone, and domperidone where available (does not cross the blood-brain barrier).

Selegiline and rasagiline are MAO-B inhibitors. Combining them with meperidine risks serotonin syndrome; meperidine is contraindicated. Indirect-acting sympathomimetics (ephedrine) may produce exaggerated pressor responses — prefer titrated phenylephrine .

Deep brain stimulators are increasingly present: use bipolar electrocautery, place the grounding pad far from the generator, and turn the device off before cautery.

2. Demyelinating Disease: Multiple Sclerosis and Guillain-Barre Syndrome

Multiple sclerosis (MS) is demyelination of the central nervous system (brain, spinal cord, optic nerve) — peripheral nerves are spared, which is exactly why the succinylcholine and regional-anesthesia questions differ from those in peripheral neuropathies.

Temperature is the highest-yield fact : an increase in core temperature of as little as 1 degree Celsius can block conduction in demyelinated axons and precipitate a relapse. Aggressively prevent hyperthermia.

Relapse is also provoked by surgical stress and infection; many exacerbations after surgery are attributed to anesthesia when the true trigger is fever or stress. Document the neurologic examination before any anesthetic.

Succinylcholine is avoided where there is significant paresis, because extrajunctional acetylcholine receptor upregulation causes hyperkalemia.

Response to nondepolarizers is unpredictable — resistance in upregulated muscle, exaggerated sensitivity where muscle mass is lost. Titrate to quantitative train-of-four.

Spinal anesthesia is relatively contraindicated by long tradition (the cord is exposed to a higher local anesthetic concentration without a protective myelin sheath); epidural and peripheral nerve blocks are considered lower risk , and general anesthesia is not associated with relapse.

Patients on chronic corticosteroids may need stress-dose coverage.

Guillain-Barre syndrome is an acute inflammatory demyelinating polyradiculoneuropathy causing ascending weakness. Key points: succinylcholine is contraindicated (hyperkalemia), autonomic instability produces wide swings in blood pressure and heart rate with exaggerated responses to indirect vasopressors, and respiratory failure requiring ventilation is common (a vital capacity below 15 mL/kg predicts the need for intubation).

3. Motor Neuron and Cortical Degeneration

Disease Core lesion Anesthetic rules

Amyotrophic lateral sclerosis (ALS) Upper and lower motor neuron degeneration Succinylcholine contraindicated (hyperkalemia); marked sensitivity to nondepolarizers; bulbar weakness = aspiration; very high risk of postoperative ventilatory failure — avoid long-acting agents and plan for possible postoperative ventilation

Alzheimer disease / dementia Cortical cholinergic deficiency Avoid central anticholinergics (atropine, scopolamine cross the blood-brain barrier); glycopyrrolate is quaternary and does not . Home cholinesterase inhibitors (donepezil, rivastigmine) prolong succinylcholine and antagonize nondepolarizers . High postoperative delirium risk

Huntington disease Autosomal dominant chorea plus dementia Reduced plasma cholinesterase activity has been reported (prolonged succinylcholine); exaggerated response to thiopental; very high aspiration risk from pharyngeal chorea

4. Peripheral Neuropathies

Diabetic, chemotherapy-induced, alcoholic, and uremic neuropathies all matter for two reasons on the NCE: (1) a documented preoperative neurologic examination is mandatory before any regional technique so that a preexisting deficit is not later attributed to the block, and (2) demyelinated or already-injured nerves are more vulnerable to a second insult — the double-crush phenomenon . This does not make regional anesthesia forbidden, but it does justify lower local anesthetic concentrations, avoidance of epinephrine adjuvants in some cases, and careful documentation and consent.

Exam Traps

The most commonly missed item is giving metoclopramide for aspiration prophylaxis to a patient with Parkinson disease. It is contraindicated.

A patient with Parkinson disease who becomes rigid and hyperthermic 12 hours after surgery has most likely missed levodopa doses , not developed malignant hyperthermia.

In MS, the danger is hyperthermia , not the anesthetic technique.

Loading diagram... Antiemetic Selection in Parkinson Disease